novo nordisk semaglutide shortage comments on role of off-label use in Ozempic shortfall An Ongoing Crisis: Semaglutide Shortage

Application of T

Composition & Specification Total Content: 80 mg lyophilised powder (requires reconstitution) Component Breakdown: GHK-Cu 50 mg BPC-157 10 mg TB-4 10 mg KPV 10 mg Purity: 99 % each peptide (HPLC / MS certificates available) Manufacturing: ISO 9001:2015 & cGMP-audited facility Intended Use: In-vitro laboratory research only Storage & Handling Before reconstitution: store 8 C in a dry environment After reconstitution: refrigerate 2 8 C and use within 30 days For long-term preservation: aliquot and freeze at 20 C Avoid repeated freezethaw cycles Compliance Notice Supplied exclusively to qualified professionals for controlled laboratory applications

J Neurosurg (2000) 92(3):413418

This guarantees that the procedures used are appropriate for the intended purpose and provide repeatable outcomes